pharmacy

PharmEasy's valuation dropped drastically to $456 million by its investor: Report

This drastic drop in valuation comes after investor Janus Henderson revealed in a filing that it lowered the value of its 12.9 million shares in the startup to $766,043—far below its original purchase price of $9.4 million.